 |
NEW! Introducing the DAISOGEL BIO series
The XXI century is often considered the era of “protein science”. Peptide and protein research are quickly maturing to be the major driving force for new kinds of pharmaceutical ingredients. For both the research and the large scale peptide and protein manufacturing, spherical silica must be tailor made and fine tuned. The new line up of DAISOGEL is designed to serve these needs, featuring extended acidic and alkalic resistance, and high loadability combined with exceptional durability.
- 12 nm pore size, narrow particle size distribution, ultra high purity totally spherical silica gel
- High density bonding for extreme performance
The improved high density bonding and full endcapping make it most suitable to separate or purify lower molecular weight compounds, especially smaller peptides. Because of significant improvement in durability, acidic, and alkalic resistance it can be used for an extended period of time under acidic mobile phase condition and rinsed for regeneration with NaOH containing solvents.The ODS phase is recommended for general use, first choice for unknown compounds.
Available types: SP-120-ODS-BIO, SP-120-C8-BIO, SP-120-C4-BIO |
| Product names and properties / SP-120-BIO series |
| |
Pore Size (nm) |
Particle Size (um) |
Pore Volume (mL/g) |
Surface Area (m2/g) |
Carbon (%) |
Minimum Lot (g) |
| SP-120-5-ODS-BIO |
12 |
5 |
1.0 |
300 |
20 |
50 |
| SP-120-10-ODS-BIO |
12 |
10 |
1.0 |
300 |
20 |
500 |
| SP-120-15-ODS-BIO |
12 |
15 |
1.0 |
300 |
20 |
500 |
| SP-120-20-ODS-BIO |
12 |
20 |
1.0 |
300 |
20 |
500 |
| SP-120-5-C8-BIO |
12 |
5 |
1.0 |
300 |
12 |
50 |
| SP-120-10-C8-BIO |
12 |
10 |
1.0 |
300 |
12 |
500 |
| SP-120-15-C8-BIO |
12 |
15 |
1.0 |
300 |
12 |
500 |
| SP-120-20-C8-BIO |
12 |
20 |
1.0 |
300 |
12 |
500 |
| SP-120-5-C4-BIO |
12 |
5 |
1.0 |
300 |
9 |
50 |
| SP-120-10-C4-BIO |
12 |
10 |
1.0 |
300 |
9 |
500 |
| SP-120-15-C4-BIO |
12 |
15 |
1.0 |
300 |
9 |
500 |
| SP-120-20-C4-BIO |
12 |
20 |
1.0 |
300 |
9 |
500 |
|
Copyright(C) 2009 DAISO. All rights reserved.
|
